BIOS [NASD]
BioPlus Acquisition Corp.
Index- P/E- EPS (ttm)-0.01 Insider Own3.73% Shs Outstand29.31M Perf Week0.10%
Market Cap294.28M Forward P/E31.34 EPS next Y0.32 Insider Trans0.00% Shs Float16.93M Perf Month0.40%
Income-0.40M PEG- EPS next Q-0.09 Inst Own82.30% Short Float0.01% Perf Quarter1.11%
Sales- P/S- EPS this Y63.30% Inst Trans4.93% Short Ratio0.03 Perf Half Y-
Book/sh7.53 P/B1.33 EPS next Y277.80% ROA-0.20% Target Price- Perf Year-
Cash/sh0.01 P/C980.93 EPS next 5Y10.00% ROE-0.20% 52W Range9.78 - 10.14 Perf YTD2.35%
Dividend- P/FCF- EPS past 5Y-9.93% ROI- 52W High-1.18% Beta-
Dividend %- Quick Ratio3.00 Sales past 5Y- Gross Margin- 52W Low2.46% ATR0.02
Employees2 Current Ratio3.00 Sales Q/Q- Oper. Margin- RSI (14)52.20 Volatility0.07% 0.09%
OptionableNo Debt/Eq0.00 EPS Q/Q- Profit Margin- Rel Volume0.00 Prev Close10.03
ShortableYes LT Debt/Eq0.02 Earnings- Payout- Avg Volume68.55K Price10.02
Recom1.40 SMA20-0.03% SMA500.43% SMA2000.81% Volume50 Change-0.10%
Jun-27-22 10:58AM
Jun-07-22 09:07AM
BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.